Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study

被引:7
作者
Okuyama, Yoshiharu [1 ]
Hatakeyama, Shingo [2 ,7 ]
Tabata, Ryuji [3 ]
Fujimori, Daiji [3 ]
Kawashima, Yohei [3 ]
Tanaka, Toshikazu [4 ]
Fujita, Naoki [1 ]
Okamoto, Teppei [1 ]
Mori, Kazuyuki [1 ]
Yamamoto, Hayato [1 ]
Yoneyama, Takahiro [5 ]
Hashimoto, Yasuhiro [1 ]
Matsuoka, Toshimitsu [6 ]
Sato, Satoshi [3 ]
Ohyama, Chikara [1 ,2 ]
机构
[1] Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Japan
[2] Hirosaki Univ, Dept Adv Blood Purificat Therapy, Grad Sch Med, Hirosaki, Japan
[3] Ageo Cent Gen Hosp, Dept Urol, Ageo, Japan
[4] Aomori Prefectural Cent Hosp, Dept Urol, Aomori, Japan
[5] Hirosaki Univ, Dept Adv Transplant & Regenerat Med, Grad Sch Med, Hirosaki, Japan
[6] Hachinohe Heiwa Hosp, Dept Urol, Hachinohe, Japan
[7] Hirosaki Univ, Dept Adv Blood Purificat Therapy, Grad Sch Med, 5 Zaifu chou, Hirosaki 0368562, Japan
基金
日本学术振兴会;
关键词
estimated glomerular filtration rate; hydronephrosis; radical nephroureterectomy; renal function; upper tract urothelial carcinoma; GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CHEMOTHERAPY; CANCER; UNFIT;
D O I
10.1111/iju.15192
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the impact of radical nephroureterectomy on postoperative renal function in patients with upper tract urothelial carcinoma (UTUC).Methods We retrospectively evaluated 645 patients with UTUC treated with radical nephroureterectomy between January 2000 and May 2022. The primary outcome was the rate of postoperative estimated glomerular filtration rate (eGFR) = 60 mL/min/1.73 m(2). Secondary outcomes included the rate of eGFR decline, identification of factors related to eGFR decline, and the impact of comorbidities (diabetes or cardiovascular disease) on postoperative eGFR at 1 year.Results The median preoperative and postoperative eGFR levels were 55.6 and 43.3 mL/min/1.73 m(2), respectively. The rate of patients with preoperative and postoperative eGFR = 60 mL/min/1.73 m(2) was 40.9% and 9.0%, respectively. The median decline in eGFR after surgery was 25.1%. The presence of preoperative unilateral hydronephrosis and eGFR <60 mL/min/1.73 m(2) was significantly associated with a low decline of postoperative eGFR and poor survival. The impact of the presence of comorbidities on postoperative eGFR at 1 year was significant (p < 0.001).Conclusion Impaired renal function is prevalent in patients with UTUC. The rate of patients with postoperative eGFR = 60 mL/min/1.73 m(2) was 9.0%. The presence of preoperative renal impairment was significantly related to a low decline in postoperative eGFR and poor survival. The presence of comorbidities had a significant effect on eGFR decline 1 year after radical nephroureterectomy.
引用
收藏
页码:649 / 657
页数:9
相关论文
共 29 条
[1]   Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma [J].
Bajorin, D. F. ;
Witjes, J. A. ;
Gschwend, J. E. ;
Schenker, M. ;
Valderrama, B. P. ;
Tomita, Y. ;
Bamias, A. ;
Lebret, T. ;
Shariat, S. F. ;
Park, S. H. ;
Ye, D. ;
Agerbaek, M. ;
Enting, D. ;
McDermott, R. ;
Gajate, P. ;
Peer, A. ;
Milowsky, M., I ;
Nosov, A. ;
Antonio Jr, J. N. ;
Tupikowski, K. ;
Toms, L. ;
Fischer, B. S. ;
Qureshi, A. ;
Collette, S. ;
Unsal-Kacmaz, K. ;
Broughton, E. ;
Zardavas, D. ;
Koon, H. B. ;
Galsky, M. D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (22) :2102-2114
[2]   Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial [J].
Birtle, Alison ;
Johnson, Mark ;
Chester, John ;
Jones, Robert ;
Dolling, David ;
Bryan, Richard T. ;
Harris, Christopher ;
Winterbottom, Andrew ;
Blacker, Anthony ;
Catto, James W. F. ;
Chakraborti, Prabir ;
Donovan, Jenny L. ;
Elliott, Paul Anthony ;
French, Ann ;
Jagdev, Satinder ;
Jenkins, Benjamin ;
Keeley, Francis Xavier, Jr. ;
Kockelbergh, Roger ;
Powles, Thomas ;
Wagstaff, John ;
Wilson, Caroline ;
Todd, Rachel ;
Lewis, Rebecca ;
Hall, Emma .
LANCET, 2020, 395 (10232) :1268-1277
[3]   Normal values for renal length and volume as measured by magnetic resonance imaging [J].
Cheong, Benjamin ;
Muthupillai, Raja ;
Rubin, Mario F. ;
Flamm, Scott D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (01) :38-45
[4]   Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 [J].
De Santis, Maria ;
Bellmunt, Joaquim ;
Mead, Graham ;
Kerst, J. Martijn ;
Leahy, Michael ;
Maroto, Pablo ;
Gil, Thierry ;
Marreaud, Sandrine ;
Daugaard, Gedske ;
Skoneczna, Iwona ;
Collette, Sandra ;
Lorent, Julie ;
de Wit, Ronald ;
Sylvester, Richard .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) :191-199
[5]   Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma [J].
Foerster, Beat ;
Abufaraj, Mohammad ;
Petros, Firas ;
Azizi, Mounsif ;
Gupta, Mohit ;
Schweitzer, Donald ;
Margulis, Vitaly ;
Iwata, Takehiro ;
Kimura, Shoji ;
Shabsigh, Ahmad ;
Briganti, Alberto ;
Ku, Ja H. ;
Muilwijk, Tim ;
Kassouf, Wassim ;
Matin, Surena F. ;
Spiess, Philippe E. ;
Pierorazio, Phillip M. ;
Hendricksen, Kees ;
Shariat, Shahrokh F. .
JOURNAL OF UROLOGY, 2020, 203 (06) :1101-1108
[6]   Treatment of Patients With Metastatic Urothelial Cancer "Unfit" for Cisplatin-Based Chemotherapy [J].
Galsky, Matthew D. ;
Hahn, Noah M. ;
Rosenberg, Jonathan ;
Sonpavde, Guru ;
Hutson, Thomas ;
Oh, William K. ;
Dreicer, Robert ;
Vogelzang, Nicholas ;
Sternberg, Cora N. ;
Bajorin, Dean F. ;
Bellmunt, Joaquim .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2432-2438
[7]   Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study [J].
Hamaya, Tomoko ;
Hatakeyama, Shingo ;
Tanaka, Toshikazu ;
Kubota, Yuka ;
Togashi, Kyo ;
Hosogoe, Shogo ;
Fujita, Naoki ;
Kusaka, Ayumu ;
Tokui, Noriko ;
Okamoto, Teppei ;
Yamamoto, Hayato ;
Yoneyama, Tohru ;
Yoneyama, Takahiro ;
Hashimoto, Yasuhiro ;
Ohyama, Chikara .
BJU INTERNATIONAL, 2021, 128 (04) :468-476
[8]   Preoperative Hydronephrosis: Independent Predictor for Changes in Renal Function Following Nephroureterectomy [J].
Hoshino, Katsura ;
Kikuchi, Eiji ;
Tanaka, Nobuyuki ;
Akita, Hirotaka ;
Ito, Yujiro ;
Miyajima, Akira ;
Jinzaki, Masahiro ;
Oya, Mototsugu .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (03) :202-207
[9]   Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy [J].
Kaag, Matthew G. ;
O'Malley, Rebecca L. ;
O'Malley, Padraic ;
Godoy, Guilherme ;
Chen, Mang ;
Smaldone, Marc C. ;
Hrebinko, Ronald L. ;
Raman, Jay D. ;
Bochner, Bernard ;
Dalbagni, Guido ;
Stifelman, Michael D. ;
Taneja, Samir S. ;
Huang, William C. .
EUROPEAN UROLOGY, 2010, 58 (04) :581-587
[10]   Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma [J].
Kido, Koichi ;
Hatakeyama, Shingo ;
Fujita, Naoki ;
Yamamoto, Hayato ;
Tobisawa, Yuki ;
Yoneyama, Tohru ;
Yoneyama, Takahiro ;
Hashimoto, Yasuhiro ;
Koie, Takuya ;
Iwabuchi, Ikuya ;
Ogasawara, Masaru ;
Kawaguchi, Toshiaki ;
Ohyama, Chikara .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (04) :726-733